Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CVITKOVIC, F")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Actualités de l'ASCO 2007 : Cancers non colorectauxCVITKOVIC, F.Oncologie (Paris). 2007, Vol 9, Num 7-8, pp 543-546, issn 1292-3818, 4 p.Conference Paper

Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabMALKA, D; BOIGE, V; GUICHARD, P et al.Annals of oncology. 2012, Vol 23, Num 4, pp 919-927, issn 0923-7534, 9 p.Article

'A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancerBENNOUNA, J; PERRIER, H; MALEK, K et al.British journal of cancer. 2006, Vol 94, Num 1, pp 69-73, issn 0007-0920, 5 p.Article

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer : Final results of a phase II studyPEIFFERT, D; GIOVANNINI, M; GERARD, J.-P et al.Annals of oncology. 2001, Vol 12, Num 3, pp 397-404, issn 0923-7534Article

Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer : A French cooperative studyPEIFFERT, D; SEITZ, J.-F; DEBRIGODE, E et al.Annals of oncology. 1997, Vol 8, Num 6, pp 575-581, issn 0923-7534Article

Facteurs pronostiques des petites tumeurs (-3 cm) au centre René-Huguenin = Prognostic factors in small breast tumors at the René-Huguenin centerTUBIANA-HULIN, M; HACENE, K; BERTHEAULT-CVITKOVIC, F et al.La Semaine des hôpitaux de Paris. 1998, Vol 74, Num 31-32, pp 1178-1179, issn 0037-1777Conference Paper

A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5-FU2 + irinotecan or LV5-FU2 + oxaliplatin) in first-line metastatic colorectal cancer : a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le CancerBECOUARN, Y; SENESSE, P; THEZENAS, S et al.Annals of oncology. 2007, Vol 18, Num 12, pp 2000-2005, issn 0923-7534, 6 p.Article

Pancréatite aiguë apparue au décours d'une chimiothérapie anticancéreuse à base de doxorubicine et vinorelbine : à propos d'un cas = Acute pancreatitis following cytotoxic therapy based of doxorubicin and vinorelbin : about a case reportGARDILLOU, L; CVITKOVIC, F; FLOIRAS, J.-L et al.Journal de pharmacie clinique (Paris). 1999, Vol 18, Num 4, pp 292-294, issn 0291-1981Article

Association mitomycine-vinorelbine en deuxième ligne chimiothérapique dans le cancer du sein métastatique = Mitomycin-vinorelbine as second line chemotherapy in metastatic breast cancerBOURGEOIS, H; TURPIN, F; GIRARD, M et al.Bulletin du cancer. 1998, Vol 85, Num 9, pp 794-798, issn 0007-4551Article

Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomasCVITKOVIC, F. B; HAIE-MEDER, C; PAPADIMITRAKOPOULOU, V et al.Journal of neuro-oncology. 1993, Vol 15, Num 1, pp 9-17, issn 0167-594XArticle

Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil : a pilot study in patients with pancreatic adenocarcinomaBERTHEAULT-CVITKOVIC, F; LEVI, F; SOUSSAN, S et al.European journal of cancer. Part A. 1993, Vol 29, Num 13, pp 1851-1854Article

Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patientsSEITZ, J.-F; BENNOUNA, J; NASCA, S et al.Annals of oncology. 2002, Vol 13, Num 7, pp 1072-1079, issn 0923-7534Article

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgeryGIACCHETTI, S; ITZHAKI, M; REYNES, M et al.Annals of oncology. 1999, Vol 10, Num 6, pp 663-669, issn 0923-7534Article

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancerBERTHEAULT-CVITKOVIC, F; JAMI, A; ITHZAKI, M et al.Journal of clinical oncology. 1996, Vol 14, Num 11, pp 2950-2958, issn 0732-183XArticle

Le traitement du cancer du sein après 70 ans. A propos de 1143 cas. Discussion = Treatment of breast cancer in the elderly. Report of 1,143 cases. DiscussionGARBAY, J. R; BERTHEAULT-CVITKOVIC, F; COHEN-SOLAL LE NIR, C et al.GARBAY, J. R; Chirurgie (Paris). 1998, Vol 123, Num 4, pp 379-386, issn 0001-4001Article

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancerGIACCHETTI, S; PERPOINT, B; BERTHEAUT-CVITKOVIC, F et al.Journal of clinical oncology. 2000, Vol 18, Num 1, pp 136-147, issn 0732-183XArticle

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumoursDELORD, J. P; PIERGA, J. Y; MERY-MIGNARD, D et al.British journal of cancer. 2005, Vol 92, Num 5, pp 820-826, issn 0007-0920, 7 p.Article

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaDUCREUX, M; ROUGIER, P; ADENIS, A et al.Annals of oncology. 2002, Vol 13, Num 8, pp 1185-1191, issn 0923-7534Article

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patientsBECOUARN, Y; YCHOU, M; DUFFOUR, J et al.Journal of clinical oncology. 1998, Vol 16, Num 8, pp 2739-2744, issn 0732-183XArticle

  • Page / 1